International Clinical Trial: Simultaneous Administration Study of Varicella Attenuated Live Vaccine and Trivalent Inactivated Influenza Vaccine (Split Virion)

Geneva, June 4 -- International Clinical Trials Registry received information related to the study (NCT06987942) titled 'Simultaneous Administration Study of Varicella Attenuated Live Vaccine and Trivalent Inactivated Influenza Vaccine (Split Virion)' on May 15.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: None (Open Label).

Primary Sponsor: Sinovac (Dalian) Vaccine Technology Co., Ltd.

Condition: Varicella Influenza Vaccine

Intervention: Biological: Varicella vaccine+TIV Biological: Varicella vaccine

Recruitment Status: Not recruiting

Phase: Phase 4

Date of First Enrollment: September 21, 2024

Target Sample Size: 899

Countr...